New

Small Molecule Targeted Therapy Market

2021

Small Molecule Targeted Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type(Monoclonal Antibodies, Small Molecules, Small Molecule Drug Conjugates)

| Report Code: TIPRE00018779 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Small Molecule Targeted Therapy Market 2028 By Type | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Small molecule targeted therapy corrects the root cause of cancer by killing the cancerous cells and halting their development. Chemotherapeutic drugs and cytotoxin medications reduce the rate of cell division which prevents cancer from developing. Targeted Cancer treatment is more effective than traditional techniques and is a much safer way to protect normal cells from toxic radiations.

MARKET DYNAMICS

Small Molecule Targeted therapy, which features a more targeted approach with less after-effects, has an improved rate of acceptance by customers. This is the main reason why the demand is rising. There's been a spike in cancer deaths, which also contributed to growth in the market. The substantial barrier for the market's growth is a steadily decreasing number of licenced chemical drugs due to more strict regulations.

MARKET SCOPE

The "Small Molecule Targeted Therapy Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Small Molecule Targeted Therapy Market with detailed market segmentation by type. The Small Molecule Targeted Therapy Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Small Molecule Targeted Therapy Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Small Molecule Targeted Therapy Market is segmented on the basis of type. Based on type, the market is segmented as Monoclonal Antibodies, Small Molecules, Small Molecule Drug Conjugates.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Small Molecule Targeted Therapy Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Small Molecule Targeted Therapy Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Small Molecule Targeted Therapy Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Small Molecule Targeted Therapy Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Small Molecule Targeted Therapy Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Small Molecule Targeted Therapy Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Small Molecule Targeted Therapy Market in the global market. Below mentioned is the list of few companies engaged in the Small Molecule Targeted Therapy Market.

The report also includes the profiles of key players in Small Molecule Targeted Therapy Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- OncoGenex Pharmaceuticals, Inc.
- Cytokinetics Inc.
- Hospira Inc.
- GlaxoSmithKline plc
- Boehringer Ingelheim GmbH
- Bayer HealthCare AG
- Abbott Laboratories.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Small Molecule Targeted Therapy Market - By Type
1.3.2 Small Molecule Targeted Therapy Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SMALL MOLECULE TARGETED THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SMALL MOLECULE TARGETED THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SMALL MOLECULE TARGETED THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. SMALL MOLECULE TARGETED THERAPY - GLOBAL MARKET OVERVIEW
6.2. SMALL MOLECULE TARGETED THERAPY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SMALL MOLECULE TARGETED THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODIES
7.3.1. Overview
7.3.2. Monoclonal Antibodies Market Forecast and Analysis
7.4. SMALL MOLECULES
7.4.1. Overview
7.4.2. Small Molecules Market Forecast and Analysis
7.5. SMALL MOLECULE DRUG CONJUGATES
7.5.1. Overview
7.5.2. Small Molecule Drug Conjugates Market Forecast and Analysis
8. SMALL MOLECULE TARGETED THERAPY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Small Molecule Targeted Therapy Market Overview
8.1.2 North America Small Molecule Targeted Therapy Market Forecasts and Analysis
8.1.3 North America Small Molecule Targeted Therapy Market Forecasts and Analysis - By Type
8.1.4 North America Small Molecule Targeted Therapy Market Forecasts and Analysis - By Countries
8.1.4.1 United States Small Molecule Targeted Therapy Market
8.1.4.1.1 United States Small Molecule Targeted Therapy Market by Type
8.1.4.2 Canada Small Molecule Targeted Therapy Market
8.1.4.2.1 Canada Small Molecule Targeted Therapy Market by Type
8.1.4.3 Mexico Small Molecule Targeted Therapy Market
8.1.4.3.1 Mexico Small Molecule Targeted Therapy Market by Type
8.2. EUROPE
8.2.1 Europe Small Molecule Targeted Therapy Market Overview
8.2.2 Europe Small Molecule Targeted Therapy Market Forecasts and Analysis
8.2.3 Europe Small Molecule Targeted Therapy Market Forecasts and Analysis - By Type
8.2.4 Europe Small Molecule Targeted Therapy Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Small Molecule Targeted Therapy Market
8.2.4.1.1 Germany Small Molecule Targeted Therapy Market by Type
8.2.4.2 France Small Molecule Targeted Therapy Market
8.2.4.2.1 France Small Molecule Targeted Therapy Market by Type
8.2.4.3 Italy Small Molecule Targeted Therapy Market
8.2.4.3.1 Italy Small Molecule Targeted Therapy Market by Type
8.2.4.4 Spain Small Molecule Targeted Therapy Market
8.2.4.4.1 Spain Small Molecule Targeted Therapy Market by Type
8.2.4.5 United Kingdom Small Molecule Targeted Therapy Market
8.2.4.5.1 United Kingdom Small Molecule Targeted Therapy Market by Type
8.2.4.6 Rest of Europe Small Molecule Targeted Therapy Market
8.2.4.6.1 Rest of Europe Small Molecule Targeted Therapy Market by Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Small Molecule Targeted Therapy Market Overview
8.3.2 Asia-Pacific Small Molecule Targeted Therapy Market Forecasts and Analysis
8.3.3 Asia-Pacific Small Molecule Targeted Therapy Market Forecasts and Analysis - By Type
8.3.4 Asia-Pacific Small Molecule Targeted Therapy Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Small Molecule Targeted Therapy Market
8.3.4.1.1 Australia Small Molecule Targeted Therapy Market by Type
8.3.4.2 China Small Molecule Targeted Therapy Market
8.3.4.2.1 China Small Molecule Targeted Therapy Market by Type
8.3.4.3 India Small Molecule Targeted Therapy Market
8.3.4.3.1 India Small Molecule Targeted Therapy Market by Type
8.3.4.4 Japan Small Molecule Targeted Therapy Market
8.3.4.4.1 Japan Small Molecule Targeted Therapy Market by Type
8.3.4.5 South Korea Small Molecule Targeted Therapy Market
8.3.4.5.1 South Korea Small Molecule Targeted Therapy Market by Type
8.3.4.6 Rest of Asia-Pacific Small Molecule Targeted Therapy Market
8.3.4.6.1 Rest of Asia-Pacific Small Molecule Targeted Therapy Market by Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Small Molecule Targeted Therapy Market Overview
8.4.2 Middle East and Africa Small Molecule Targeted Therapy Market Forecasts and Analysis
8.4.3 Middle East and Africa Small Molecule Targeted Therapy Market Forecasts and Analysis - By Type
8.4.4 Middle East and Africa Small Molecule Targeted Therapy Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Small Molecule Targeted Therapy Market
8.4.4.1.1 South Africa Small Molecule Targeted Therapy Market by Type
8.4.4.2 Saudi Arabia Small Molecule Targeted Therapy Market
8.4.4.2.1 Saudi Arabia Small Molecule Targeted Therapy Market by Type
8.4.4.3 U.A.E Small Molecule Targeted Therapy Market
8.4.4.3.1 U.A.E Small Molecule Targeted Therapy Market by Type
8.4.4.4 Rest of Middle East and Africa Small Molecule Targeted Therapy Market
8.4.4.4.1 Rest of Middle East and Africa Small Molecule Targeted Therapy Market by Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Small Molecule Targeted Therapy Market Overview
8.5.2 South and Central America Small Molecule Targeted Therapy Market Forecasts and Analysis
8.5.3 South and Central America Small Molecule Targeted Therapy Market Forecasts and Analysis - By Type
8.5.4 South and Central America Small Molecule Targeted Therapy Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Small Molecule Targeted Therapy Market
8.5.4.1.1 Brazil Small Molecule Targeted Therapy Market by Type
8.5.4.2 Argentina Small Molecule Targeted Therapy Market
8.5.4.2.1 Argentina Small Molecule Targeted Therapy Market by Type
8.5.4.3 Rest of South and Central America Small Molecule Targeted Therapy Market
8.5.4.3.1 Rest of South and Central America Small Molecule Targeted Therapy Market by Type
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SMALL MOLECULE TARGETED THERAPY MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SMALL MOLECULE TARGETED THERAPY MARKET, KEY COMPANY PROFILES
11.1. ONCOGENEX PHARMACEUTICALS, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CYTOKINETICS INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. HOSPIRA INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PLC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BOEHRINGER INGELHEIM GMBH
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BAYER HEALTHCARE AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ABBOTT LABORATORIES.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. OncoGenex Pharmaceuticals, Inc.
2. Cytokinetics Inc.
3. Hospira Inc.
4. GlaxoSmithKline plc
5. Boehringer Ingelheim GmbH
6. Bayer HealthCare AG
7. Abbott Laboratories.
TIPRE00018779
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.